Valuation: Net Medical Xpress Solutions, Inc.

Market Cap 10.74L 9L 9L 8L 15.13L 10Cr 15.5L 1.04Cr 40.84L 5.09Cr 40.31L 39.43L 18Cr P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 8L 7L 7L 6L 11.65L 7.92Cr 11.93L 80.4L 31.44L 3.92Cr 31.04L 30.36L 14Cr EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
1 week-85.71%
Current month-85.71%
1 month-85.71%
3 months-85.71%
6 months-66.67%
Current year-66.67%
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.03
5 years 0
Extreme 0
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 26/06/2019
Director TitleAgeSince
Director/Board Member 64 01/01/2003
Director/Board Member 84 01/01/2005
Director/Board Member - 01/03/2018
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-85.71%-.--%-99.60% 26.4T
-0.71%+0.05%-23.81%+15.42% 2,90100Cr
-0.43%-1.26%-21.27%+590.62% 29TCr
+1.68%-12.45%+140.42%+962.74% 11TCr
-3.47%-1.26%-9.15%+42.06% 9.18TCr
+5.31%+7.50%+75.82%+135.49% 9.4TCr
-2.64%-1.04%-41.23%-17.12% 7.16TCr
+0.89%+3.33%-32.46%+70.07% 6.64TCr
-0.48%+5.50%+10.02%+62.55% 4.61TCr
+1.27%+0.99%-57.64%+28.77% 3.59TCr
Average +0.98%+0.61%+4.07%+179.10% 37.08TCr
Weighted average by Cap. +6.02%-0.00%-16.40%+93.11%

Financials

2015 2016
Net sales 42.22L 37.1L 34.63L 31.78L 59.49L 40Cr 60.96L 4.11Cr 1.61Cr 20Cr 1.59Cr 1.55Cr 69Cr 30.45L 26.76L 24.98L 22.92L 42.91L 29Cr 43.96L 2.96Cr 1.16Cr 14Cr 1.14Cr 1.12Cr 50Cr
Net income 2L 1L 1L 1L 2L 1.45Cr 2L 14.69L 6L 71.57L 6L 6L 2.47Cr -3L -3L -3L -3L -5L -3.29Cr -5L -33.46L -13.08L -1.63Cr -12.92L -12.64L -5.64Cr
Net Debt -3L -3L -3L -3L -5L -3.26Cr -5L -33.07L -12.93L -1.61Cr -12.77L -12.49L -5.57Cr -2L -2L -2L -2L -3L -2.37Cr -4L -24.02L -9L -1.17Cr -9L -9L -4.05Cr
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. NMXS Stock